Cargando…
The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
BACKGROUND: Psoriasis is a serious and chronic noncommunicable disease. However, the fundamental measure of disease occurrence, the incidence, has been scarcely reported globally. There are no previous studies of psoriasis incidence in Latin America. AIM: To estimate the incidence rates of psoriasis...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518053/ https://www.ncbi.nlm.nih.gov/pubmed/33914930 http://dx.doi.org/10.1111/ced.14713 |
_version_ | 1784584140454100992 |
---|---|
author | Lecaros, C. Dunstan, J. Villena, F. Ashcroft, D. M. Parisi, R. Griffiths, C. E. M. Härtel, S. Maul, J. T. De la Cruz, C. |
author_facet | Lecaros, C. Dunstan, J. Villena, F. Ashcroft, D. M. Parisi, R. Griffiths, C. E. M. Härtel, S. Maul, J. T. De la Cruz, C. |
author_sort | Lecaros, C. |
collection | PubMed |
description | BACKGROUND: Psoriasis is a serious and chronic noncommunicable disease. However, the fundamental measure of disease occurrence, the incidence, has been scarcely reported globally. There are no previous studies of psoriasis incidence in Latin America. AIM: To estimate the incidence rates of psoriasis in Chile during 2016 and 2017 using an administrative database, the Waiting List Repository. METHODS: We examined referrals of psoriasis at onset, made by physicians to dermatologists, evaluated the agreement of diagnosis, and estimated the incidence of the disease considering the eligible population at risk. RESULTS: In most cases, the referrals corresponded to incident cases of psoriasis (73.3%; 95% CI: 66.6–79.2). The national incidence rates of psoriasis were 22.1 (95% CI: 21.1–23.1) and 22.7 (95% CI: 21.8–23.6) per 100 000 person‐years in 2016 and 2017, respectively. The most common type of psoriasis was the late‐onset type. We observed a high variation in the figures throughout the country, with a range from 0.75 (95% CI: 0.3–1.5) per 100 000 person‐years in the Metropolitan region to 164.9 (95% CI: 138.6–195.1) per 100 000 person‐years in the Aysen region. CONCLUSION: We describe for the first time the incidence of psoriasis in a Latin American country. Our findings could potentially guide collaborations to improve our global understanding of psoriasis in Latin America. |
format | Online Article Text |
id | pubmed-8518053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85180532021-10-21 The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository Lecaros, C. Dunstan, J. Villena, F. Ashcroft, D. M. Parisi, R. Griffiths, C. E. M. Härtel, S. Maul, J. T. De la Cruz, C. Clin Exp Dermatol Original Articles BACKGROUND: Psoriasis is a serious and chronic noncommunicable disease. However, the fundamental measure of disease occurrence, the incidence, has been scarcely reported globally. There are no previous studies of psoriasis incidence in Latin America. AIM: To estimate the incidence rates of psoriasis in Chile during 2016 and 2017 using an administrative database, the Waiting List Repository. METHODS: We examined referrals of psoriasis at onset, made by physicians to dermatologists, evaluated the agreement of diagnosis, and estimated the incidence of the disease considering the eligible population at risk. RESULTS: In most cases, the referrals corresponded to incident cases of psoriasis (73.3%; 95% CI: 66.6–79.2). The national incidence rates of psoriasis were 22.1 (95% CI: 21.1–23.1) and 22.7 (95% CI: 21.8–23.6) per 100 000 person‐years in 2016 and 2017, respectively. The most common type of psoriasis was the late‐onset type. We observed a high variation in the figures throughout the country, with a range from 0.75 (95% CI: 0.3–1.5) per 100 000 person‐years in the Metropolitan region to 164.9 (95% CI: 138.6–195.1) per 100 000 person‐years in the Aysen region. CONCLUSION: We describe for the first time the incidence of psoriasis in a Latin American country. Our findings could potentially guide collaborations to improve our global understanding of psoriasis in Latin America. John Wiley and Sons Inc. 2021-06-26 2021-10 /pmc/articles/PMC8518053/ /pubmed/33914930 http://dx.doi.org/10.1111/ced.14713 Text en © 2021 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Lecaros, C. Dunstan, J. Villena, F. Ashcroft, D. M. Parisi, R. Griffiths, C. E. M. Härtel, S. Maul, J. T. De la Cruz, C. The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository |
title | The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository |
title_full | The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository |
title_fullStr | The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository |
title_full_unstemmed | The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository |
title_short | The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository |
title_sort | incidence of psoriasis in chile: an analysis of the national waiting list repository |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518053/ https://www.ncbi.nlm.nih.gov/pubmed/33914930 http://dx.doi.org/10.1111/ced.14713 |
work_keys_str_mv | AT lecarosc theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT dunstanj theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT villenaf theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT ashcroftdm theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT parisir theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT griffithscem theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT hartels theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT mauljt theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT delacruzc theincidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT lecarosc incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT dunstanj incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT villenaf incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT ashcroftdm incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT parisir incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT griffithscem incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT hartels incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT mauljt incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository AT delacruzc incidenceofpsoriasisinchileananalysisofthenationalwaitinglistrepository |